Table 2.
Cox proportional hazard ratios (HR) for long-term all-cause mortality.
| Different base crowd | Different LVEF | Hazard ratios (95% CI), P-value |
P for interaction |
||
|---|---|---|---|---|---|
| Model 1* | Model 2$ | Model 3§ | |||
| None or Mild MR | LVEF ≥ 50% | Ref | Ref | Ref | 0.29 |
| 40% ≤ LVEF <50% | 1.65 (1.49–1.82), <0.001 | 1.65 (1.50–1.83), <0.001 | 1.45 (1.29–1.63), <0.001 | ||
| LVEF <40% | 2.38 (2.13–2.66), <0.001 | 2.27 (2.03–2.54), <0.001 | 1.79 (1.56–2.05), <0.001 | ||
| Moderate or Severe MR | LVEF ≥ 50% | Ref | Ref | Ref | |
| 40% ≤ LVEF <50% | 1.56 (1.30–1.88), <0.001 | 1.55 (1.29–1.86), <0.001 | 1.39 (1.13–1.71), 0.002 | ||
| LVEF <40% | 2.23 (1.91–2.60), <0.001 | 2.27 (1.94–2.65), <0.001 | 1.57 (1.29–1.91), <0.001 | ||
Unadjusted.
adjusted for age and gender.
adjusted for age, gender, hypertension, diabetes mellitus, acute myocardial infarction, congestive heart failure, chronic kidney diseases, atrial fibrillation, stroke, anemia, percutaneous coronary intervention, hyperlipidemia, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta-blockers, calcium channel blocker, statins, antiplatelet, mineralocorticoid receptor antagonist, loop diuretics, and oral anticoagulants. MR, mitral regurgitation; LVEF, left ventricular ejection fraction.